Business Description
Pacific Edge Ltd
NAICS : 325413
ISIN : NZPEBE0002S1
Description
Pacific Edge Ltd is a NewZealand based company involved in developing and commercializing diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. The company operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses world wide; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, New Zealand, and the Rest of the World.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 12.34 | |||||
| Equity-to-Asset | 0.84 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | -0.12 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 0.91 | |||||
| Beneish M-Score | -3.17 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 42.8 | |||||
| 3-Year EBITDA Growth Rate | -26 | |||||
| 3-Year EPS without NRI Growth Rate | -24.9 | |||||
| 3-Year FCF Growth Rate | -21.6 | |||||
| 3-Year Book Growth Rate | 27.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 25.26 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 83.79 | |||||
| 9-Day RSI | 66.05 | |||||
| 14-Day RSI | 60.09 | |||||
| 6-1 Month Momentum % | 74.19 | |||||
| 12-1 Month Momentum % | 57.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.96 | |||||
| Quick Ratio | 6.76 | |||||
| Cash Ratio | 6.04 | |||||
| Days Sales Outstanding | 51.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.7 | |||||
| Shareholder Yield % | -1.04 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -153.86 | |||||
| Net Margin % | -123.54 | |||||
| FCF Margin % | -113.45 | |||||
| ROE % | -44.67 | |||||
| ROA % | -39.47 | |||||
| ROIC % | -498.75 | |||||
| 3-Year ROIIC % | -461.58 | |||||
| ROC (Joel Greenblatt) % | -676.46 | |||||
| ROCE % | -54.6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.84 | |||||
| PB Ratio | 2.12 | |||||
| Price-to-Tangible-Book | 2.15 | |||||
| EV-to-EBIT | -1.88 | |||||
| EV-to-EBITDA | -2.03 | |||||
| EV-to-Revenue | 2.9 | |||||
| EV-to-FCF | -2.55 | |||||
| Price-to-Net-Current-Asset-Value | 2.59 | |||||
| Price-to-Net-Cash | 3.1 | |||||
| Earnings Yield (Greenblatt) % | -53.19 | |||||
| FCF Yield % | -23.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pacific Edge Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NZ$) | 26.062 | ||
| EPS (TTM) (NZ$) | -0.039 | ||
| Beta | 1.34 | ||
| Volatility % | 59.64 | ||
| 14-Day RSI | 60.09 | ||
| 14-Day ATR (NZ$) | 0.006233 | ||
| 20-Day SMA (NZ$) | 0.14775 | ||
| 12-1 Month Momentum % | 57.28 | ||
| 52-Week Range (NZ$) | 0.071 - 0.185 | ||
| Shares Outstanding (Mil) | 811.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pacific Edge Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pacific Edge Ltd Stock Events
| Event | Date | Price(NZ$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pacific Edge Ltd Frequently Asked Questions
What is Pacific Edge Ltd(NZSE:PEB)'s stock price today?
The current price of NZSE:PEB is NZ$0.16. The 52 week high of NZSE:PEB is NZ$0.19 and 52 week low is NZ$0.07.
When is next earnings date of Pacific Edge Ltd(NZSE:PEB)?
The next earnings date of Pacific Edge Ltd(NZSE:PEB) is 2024-11-22 Est..
Does Pacific Edge Ltd(NZSE:PEB) pay dividends? If so, how much?
Pacific Edge Ltd(NZSE:PEB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers